Register of
Medicinal Products
Human medicines
Veterinary medicines
Medical nutritions
User
Listings
Data download
Veterinary medicines
Search for medicinal products
Search for packages
ATC tree
Print
Gabbrovet Multi
General data
Product class:
Authorized package
Medicinal product class:
Veterinary medicine
Package code:
1848674
Name of medicinal product:
Gabbrovet Multi
Active substances:
Paromomycin
Estonian
,
English
,
Latin
ATC code:
QA07AA06
Dosage form:
solution for use in drinking water/milk
Route of administration:
in drinking water/milk use
Strengh:
140mg 1ml
Amount in package:
125ml 1TK
Legal status for supply*:
Subject to medicinal prescription
Class of active substance:
Additional information:
Indication:
Cattle (pre ruminant cattle): Colibacillosis Treatment of gastro-intestinal infections caused by Escherichia coli susceptible to paromomycin. Cattle (newborn calves): Cryptosporidiosis Treatment of infections caused by diagnosed Cryptosporidium parvum, by reduction of diarrhoea and reduction of faecal oocyst shedding. Administration has to start within 24 hours after the onset of diarrhoea. Pigs: Colibacillosis Treatment of gastro-intestinal infections caused by Escherichia coli susceptible to paromomycin.
Safety features:
No
Summary of product characteristics (SPC):
(last updated June 30, 2022)
Package information leaflet (PIL):
EST
(last updated June 30, 2022)
Labelling:
(last updated June 30, 2022)
Withdrawal time:
Veis (veised vatsaseede eelsel perioodil ja vastsündinud vasikad): - Kolibatsilloos: annus: 25-50 mg/kg/päevas 3 kuni 5 päeva. Lihale ja söödavatele kudedele: 20 päeva - Krüptosporidioos: annus: 150 mg/kg/päevas 5 päeva. Lihale ja söödavatele kudedele: 110 päeva Siga: lihale ja söödavatele kudedele: 3 päeva Paromomütsiini kuhjumise tõttu maksas ja neerudes tuleb keeluaja jooksul ravikuuri kordamist vältida.
Species:
siga, veis
Last imported to Estonia:
Never imported to Estonia
Marketing authorization
Marketing authorization holder:
Ceva Sante Animale
Marketing authorization number:
2367
Marketing authorization issued on:
June 30, 2022
Marketing authorization expires on:
Unlimited
Marketing authorization procedure type:
Decentralised
Entry/Changing date: June 30, 2022
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader from
here